TRIM26 (Tripartite Motif-Containing 26) is a member of the TRIM protein family, characterized by a conserved N-terminal RBCC domain (RING finger, B-box, and coiled-coil motifs) and a C-terminal PRY/SPRY domain. It is encoded within the major histocompatibility complex (MHC) class I region on human chromosome 6p21.3. suggesting potential roles in immune regulation. TRIM26 functions as an E3 ubiquitin ligase, mediating protein ubiquitination to modulate immune signaling pathways, including interferon (IFN) responses and NF-κB activation. Studies highlight its involvement in antiviral defense, where it may either promote or inhibit viral replication depending on the pathogen. For example, TRIM26 targets IRF3 for degradation to attenuate IFN-β production during viral infection, yet it also restricts hepatitis B virus replication by stabilizing MAVS. TRIM26 antibodies are essential tools for detecting endogenous TRIM26 expression, studying its subcellular localization (predominantly nuclear), and exploring its interactions with immune-related proteins. These antibodies are widely used in techniques like Western blotting, immunofluorescence, and immunoprecipitation. Dysregulation of TRIM26 has been linked to cancers, autoimmune diseases, and viral infections, making it a focus for therapeutic research. Validated antibodies ensure specificity, often confirmed by knockout controls, to avoid cross-reactivity with other TRIM family members.